drugset / Trial / NCT00069082
Intranasal Civamide for Episodic Cluster Headache
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
Timeline
- Start
- 2003-08
- Primary completion
- 2004-01
- Completion
- 2004-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Zucapsaicin | Small molecule | 0.01 % | Intranasal |